Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 22, 2004 06:23 ET | Source: Arexis

Arexis Gets EU Funding for a Clinical Study on Improved Nutrition in Pre-term Infants

GOTHENBURG, Sweden, Sept. 22, 2004 (PRIMEZONE) -- The Gothenburg-based drug development company Arexis AB today announced that its novel project on bile salt-stimulated lipase (BSSL), an enzyme...
February 17, 2004 06:04 ET | Source: Arexis

Arexis acquires project in lipid metabolism

GOTHENBURG, Sweden, Feb. 17, 2004 (PRIMEZONE) -- Arexis has acquired a project concerning human bile salt stimulated lipase, BSSL, from AstraZeneca. The aim of the project is to develop a new type of...
July 08, 2003 08:36 ET | Source: Arexis

Arexis AB has Today Initiated a Phase II Clinical Study in the Area of Lipid Metabolism

GOTHENBURG, Sweden, July 8, 2003 (PRIMEZONE) -- Arexis AB has today initiated a phase II clinical study in the area of lipid metabolism. The study will be completed before the end of this year....
July 01, 2003 05:54 ET | Source: Arexis

Swedish Drug Discovery Company Arexis AB Raises SEK 63 Million

GOTHENBURG, Sweden, July 01, 2003 (PRIMEZONE) -- Swedish drug discovery company Arexis AB raises SEK 63 million Arexis AB today announced the completion of a 63 million SEK private placement in...
February 12, 2003 05:10 ET | Source: Arexis

Arexis: Patent Approval for Treating Common Skin Disorders

STOCKHOLM, Sweden, Feb. 12, 2003 (PRIMEZONE) -- Arexis AB has received approval for a breakthrough patent application in Europe, covering a new method for treating the most common skin disorders. The...